Asian Journal of Medical Principles and Clinical Practice

Parkinson's disease (PD), characterized by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc), is a debilitating neurodegenerative disorder. While genetic factors contribute, environmental toxins like Arsenic (As) have been implicated in PD pathogenesis. This review examines the current understanding of arsenic-induced dopaminergic neurodegeneration, focusing on the specific pathological mechanisms triggered by arsenic exposure within the SNpc. A comprehensive literature search was conducted using databases such as PubMed, Scopus, and Web of Science. Search terms included "arsenic," "dopaminergic neurons," "substantia nigra," "neurodegeneration," "Parkinson's disease," "oxidative stress," "inflammation," "mitochondrial dysfunction," and "protein aggregation." Studies included were prioritized based on their relevance to arsenic's effects on dopaminergic neurons in the SNpc and the underlying cellular and molecular mechanisms. Exposure to arsenic induces a cascade of pathological events in dopaminergic neurons of the SNpc. Key mechanisms include: (1) Oxidative stress: Arsenic promotes the generation of reactive oxygen species (ROS), leading to lipid peroxidation, DNA damage, and protein oxidation. (2) Mitochondrial dysfunction: Arsenic disrupts mitochondrial respiration, impairs ATP production, and increases ROS generation, further exacerbating oxidative stress. (3) Inflammation: Arsenic activates microglia and astrocytes, leading to the release of pro-inflammatory cytokines that contribute to neuronal damage. (4) Protein aggregation: These interconnected pathways ultimately compromise neuronal function and survival, resulting in dopaminergic neurodegeneration.

In conclusion, Arsenic exposure represents a significant environmental risk factor for dopaminergic neurodegeneration. Understanding the precise molecular mechanisms through which arsenic triggers neuronal damage in the SNpc is crucial for developing effective preventative and therapeutic strategies to mitigate the risk of Parkinson's disease and other related neurodegenerative disorders. Further research is warranted to investigate potential interventions targeting the specific pathways activated by arsenic, such as antioxidant therapies, anti-inflammatory agents, and strategies to promote mitochondrial health and protein homeostasis.